NCT00563394View on ClinicalTrials.gov

MSI-78 Topical Cream vs. Oral Ofloxacin in the Treatment of Infected Diabetic Ulcers

PHASE3CompletedINTERVENTIONAL
Enrollment

584

Participants

Timeline

Start Date

August 31, 1994

Primary Completion Date

July 31, 1996

Study Completion Date

July 31, 1996

Conditions
Diabetic Foot Ulcers
Interventions
DRUG

ofloxacin

400 mg twice a day for 14 days

DRUG

MSI-78

1%/2% topical cream twice a day for 14 days

Trial Locations (1)

98108-1597

Seattle VA Medical Center, Seattle

Sponsors

Collaborators (1)

Genaera Corporation
All Listed Sponsors
collaborator

Genaera Corporation

INDUSTRY

lead

Abeona Therapeutics, Inc

INDUSTRY